Longitudinal Monitoring of Apparent Diffusion Coefficient (ADC) In Patients with Prostate Cancer Undergoing MR-guided Radiotherapy on an MR-Linac at 1.5 T

URN:NBN:SI:doc-Y4CVMVYZ2023Almansour, Haidaradocuments/doc/Y/URN_NBN_SI_doc-Y4CVMVYZ_001.pdfdocuments/doc/Y/URN_NBN_SI_doc-Y4CVMVYZ_001.txt257articlestr. 184-190, VI10.2478/raon-2023-00201318-2099228023555URN:NBN:SI:doc-Y4CVMVYZengCroatian Medical Association - Croatian Society of RadiologySlovenian Medical Society - Section of RadiologyRadiology and oncology (Ljubljana)BYbiomarkerjidiagnostikamagnetna resonancaradioterapijarak prostateLongitudinal Monitoring of Apparent Diffusion Coefficient (ADC) In Patients with Prostate Cancer Undergoing MR-guided Radiotherapy on an MR-Linac at 1.5 Ta prospect feasibility study